Vontobel Holding’s IN8bio INAB Stock Holding History

Vontobel Holding’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-333	Closed	-$11.8K	–	1117
2024 Q1	$11.8K	Hold	333	–	–	﹤0.01%	1082
2023 Q4	$13.9K	Buy	+333	New	+$10.6K	﹤0.01%	1095

Other funds holding INAB

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Vontobel Holding's INAB Position: Q2 2024 in Review

Vontobel Holding sold out of IN8bio (INAB) in Q2 2024, closing a stake of 333 shares — an estimated $11.8K sold.

Vontobel Holding first reported a position in INAB in Q4 2023 and held it in 2 quarters. The position peaked at $13.9K in Q4 2023. 26 funds tracked by Wall St. Rank hold INAB as of Q2 2024.

Vontobel Holding reported no remaining IN8bio position as of Q2 2024 after selling out during the quarter.
Vontobel Holding sold 333 IN8bio shares in Q2 2024, an estimated $11.8K.
Vontobel Holding first reported a position in IN8bio in Q4 2023 and held it in 2 quarters.
Vontobel Holding's IN8bio position peaked at $13.9K in Q4 2023.
26 funds tracked by Wall St. Rank held IN8bio as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.